{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:49:41Z","timestamp":1776282581005,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypoglycemia is one of the most common complications in patients with DN during hemodialysis. The purpose of the study is to construct a clinical automatic calculation to predict risk of hypoglycemia during hemodialysis for patients with diabetic nephropathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study, patients provided information for the questionnaire and received blood glucose tests during hemodialysis. The data were analyzed with logistic regression and then an automated calculator for risk prediction was constructed based on the results. From May to November 2022, 207 hemodialysis patients with diabetes nephropathy were recruited. Patients were recruited at blood purifying facilities at two hospitals in Beijing and Inner Mongolia province, China. Hypoglycemia is defined according to the standards of medical care in diabetes issued by ADA (2021). The blood glucose meter was used uniformly for blood glucose tests 15\u00a0minutes before the end of hemodialysis or when the patient did not feel well during hemodialysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence of hypoglycemia during hemodialysis was 50.2% (104\/207). The risk prediction model included 6 predictors, and was constructed as follows: Logit (<jats:italic>P<\/jats:italic>)\u2009=\u20091.505\u00d7hemodialysis duration 8~15 years (<jats:italic>OR<\/jats:italic>\u2009=\u20094.506, 3 points)\u2009+\u20091.616\u00d7hemodialysis duration 16~21 years (<jats:italic>OR<\/jats:italic>\u2009=\u20095.032, 3 points)\u2009+\u20091.504\u00d7having hypotension during last hemodialysis (<jats:italic>OR<\/jats:italic>\u2009=\u20094.501, 3 points)\u2009+\u20090.788\u00d7having hyperglycemia during the latest hemodialysis night (<jats:italic>OR<\/jats:italic>\u2009=\u20092.199, 2 points)\u2009+\u20090.91\u00d7disturbance of potassium metabolism (<jats:italic>OR<\/jats:italic>\u2009=\u20092.484, 2 points)\u2009+\u20092.636\u00d7serum albumin&lt;35\u00a0g\/L (<jats:italic>OR<\/jats:italic>\u2009=\u200913.963, 5 points)-4.314. The AUC of the prediction model was 0.866, with Matthews correlation coefficient (MCC) of 0.633, and Hosmer-Lemeshow <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> of 4.447(<jats:italic>P<\/jats:italic>\u2009=\u20090.815). The automatic calculation has a total of 18 points and four risk levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The incidence of hypoglycemia during hemodialysis is high in patients with DN. The risk prediction model in this study had a good prediction outcome. The hypoglycemia prediction automatic calculation that was developed using this model can be used to predict the risk of hypoglycemia in DN patients during hemodialysis and also help identify those with a high risk of hypoglycemia during hemodialysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-023-01177-9","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:01:58Z","timestamp":1697173318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a clinical automatic calculation of hypoglycemia during hemodialysis risk in patients with diabetic nephropathy"],"prefix":"10.1186","volume":"15","author":[{"given":"Rui-Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ning","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"10","key":"1177_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11892-018-1044-y","volume":"18","author":"R Iyengar","year":"2018","unstructured":"Iyengar R, Franzese J, Gianchandani R. Inpatient Glycemic Management in the setting of renal Insufficiency\/Failure\/Dialysis. Curr Diab Rep. 2018;18(10):75.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"1177_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11892-018-0980-x","volume":"18","author":"OK Duru","year":"2018","unstructured":"Duru OK, Middleton T, Tewari MK, Norris K. The Landscape of Diabetic kidney disease in the United States. Curr Diab Rep. 2018;18(3):14.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"1177_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.kint.2020.09.003","volume":"98","author":"C Yang","year":"2020","unstructured":"Yang C, Gao B, Zhao X, Su Z, Sun X, Wang HY, et al. Executive Summary for China kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int. 2020;98(6):1419\u201323.","journal-title":"Kidney Int"},{"issue":"7","key":"1177_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2337\/dc08-1688","volume":"32","author":"S Kazempour-Ardebili","year":"2009","unstructured":"Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, Frankel AH, Tam FW, Dornhorst A, et al. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care. 2009;32(7):1137\u201342.","journal-title":"Diabetes Care"},{"issue":"3","key":"1177_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kint.2019.03.006","volume":"96","author":"L Bally","year":"2019","unstructured":"Bally L, Gubler P, Thabit H, Hartnell S, Ruan Y, Wilinska ME, et al. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis. Kidney Int. 2019;96(3):593\u20136.","journal-title":"Kidney Int"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2017.07.033","volume":"133","author":"M Alsahli","year":"2017","unstructured":"Alsahli M, Gerich JE. Renal glucose metabolism in normal physiological conditions and in diabetes. Diabetes Res Clin Pract. 2017;133:1\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1177_CR7","doi-asserted-by":"publisher","first-page":"e0174601","DOI":"10.1371\/journal.pone.0174601","volume":"12","author":"YW Chu","year":"2017","unstructured":"Chu YW, Lin HM, Wang JJ, Weng SF, Lin CC, Chien CC. Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: a national cohort study. PLoS ONE. 2017;12(3):e0174601.","journal-title":"PLoS ONE"},{"issue":"6","key":"1177_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4239\/wjd.v6.i6.840","volume":"6","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Hasegawa H, Tsuji M, Udaka Y, Mihara M, Shimizu T, et al. Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors. World J Diabetes. 2015;6(6):840\u20139.","journal-title":"World J Diabetes"},{"issue":"5","key":"1177_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/1744-9987.12547","volume":"21","author":"M Maekawa","year":"2017","unstructured":"Maekawa M, Takahashi A, Miki Y. Carvedilol Associated Hypoglycemia in a Diabetic patient on maintenance hemodialysis. Ther Apher Dial. 2017;21(5):513\u20134.","journal-title":"Ther Apher Dial"},{"issue":"2","key":"1177_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1744-9987.2009.00662.x","volume":"13","author":"CY Sun","year":"2009","unstructured":"Sun CY, Lee CC, Wu MS. Hypoglycemia in diabetic patients undergoing chronic hemodialysis. Ther Apher Dial. 2009;13(2):95\u2013102.","journal-title":"Ther Apher Dial"},{"issue":"6","key":"1177_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/17434440.2018.1473031","volume":"15","author":"FF Li","year":"2018","unstructured":"Li FF, Xie Y, Shi BY, Niu M, Guo H, Cao Y, et al. The real world of blood glucose point-of-care testing (POCT) system running in China teaching hospital. Expert Rev Med Devices. 2018;15(6):445\u201351.","journal-title":"Expert Rev Med Devices"},{"key":"1177_CR12","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ"},{"issue":"8","key":"1177_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137.","journal-title":"Ann Intern Med"},{"key":"1177_CR14","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021, 44(Supplement 1): S73-S84.","DOI":"10.2337\/dc21-S006"},{"issue":"4","key":"1177_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kint.2020.06.019","volume":"98","author":"IH de Boer","year":"2020","unstructured":"de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, et al. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in chronic kidney disease. Kidney Int. 2020;98(4):1\u2013S115.","journal-title":"Kidney Int"},{"issue":"7","key":"1177_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1001\/jamainternmed.2015.1679","volume":"175","author":"CA Austin","year":"2015","unstructured":"Austin CA, Mohottige D, Sudore RL, Smith AK, Hanson LC. Tools to Promote Shared decision making in Serious Illness: a systematic review. JAMA Intern Med. 2015;175(7):1213\u201321.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"1177_CR17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1177_CR18","doi-asserted-by":"crossref","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB, Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631\u201360.","DOI":"10.1002\/sim.1742"},{"issue":"1","key":"1177_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gie.2020.11.012","volume":"94","author":"B Li","year":"2021","unstructured":"Li B, Shi Q, Xu EP, Yao LQ, Cai SL, Qi ZP, et al. Prediction of technically difficult endoscopic submucosal dissection for large superficial colorectal tumors: a novel clinical score model. Gastrointest Endosc. 2021;94(1):133\u201344.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"1177_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1932296817747620","volume":"12","author":"RY Gianchandani","year":"2018","unstructured":"Gianchandani RY, Neupane S, Heung M. Hypoglycemia in hospitalized Hemodialysis patients with diabetes: an observational study. J Diabetes Sci Technol. 2018;12(1):33\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"1177_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.sjbs.2017.11.019","volume":"24","author":"Q Chen","year":"2017","unstructured":"Chen Q, Zhu A, Wang J, Huan X. Comparative analysis of diabetic nephropathy and non-diabetic nephropathy disease. Saudi J Biol Sci. 2017;24(8):1815\u20137.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"1177_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209\u201390.","journal-title":"Mol Aspects Med"},{"issue":"8","key":"1177_CR23","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1681\/ASN.2006121409","volume":"18","author":"DT Lin-Tan","year":"2007","unstructured":"Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, Liu L, et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol. 2007;18(8):2385\u201391.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1177_CR24","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.3390\/nu13072282","volume":"13","author":"V Masola","year":"2021","unstructured":"Masola V, Bonomini M, Onisto M, Ferraro PM, Arduini A, Gambaro G. Biological Effects of XyloCore, a glucose sparing PD solution, on Mesothelial cells: Focus on Mesothelial-Mesenchymal transition, inflammation and angiogenesis. Nutrients. 2021;13(7):2282.","journal-title":"Nutrients"},{"issue":"6","key":"1177_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1053\/j.ajkd.2010.12.023","volume":"57","author":"M Wagner","year":"2011","unstructured":"Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2011;57(6):894\u2013902.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"5","key":"1177_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrneph.2015.38","volume":"11","author":"M Abe","year":"2015","unstructured":"Abe M, Kalantar-Zadeh K. Haemodialysis-induced hypoglycaemia and glycaemic disarrays. Nat Rev Nephrol. 2015;11(5):302\u201313.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"1177_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2215\/CJN.12141017","volume":"13","author":"PB Reeves","year":"2018","unstructured":"Reeves PB, Mc Causland FR, Mechanisms. Clinical implications, and treatment of Intradialytic Hypotension. Clin J Am Soc Nephrol. 2018;13(8):1297\u2013303.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1177_CR28","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.3390\/ijerph18052364","volume":"18","author":"JA G\u00f3mez-Pulido","year":"2021","unstructured":"G\u00f3mez-Pulido JA, G\u00f3mez-Pulido JM, Rodr\u00edguez-Puyol D, Polo-Luque ML, Vargas-Lombardo M. Predicting the Appearance of Hypotension during Hemodialysis Sessions using machine learning classifiers. Int J Environ Res Public Health. 2021;18(5):2364.","journal-title":"Int J Environ Res Public Health"},{"key":"1177_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000485695","volume":"196","author":"N Maruyama","year":"2018","unstructured":"Maruyama N, Abe M. Targets and therapeutics for Glycemic Control in Diabetes patients on Hemodialysis. Contrib Nephrol. 2018;196:37\u201343.","journal-title":"Contrib Nephrol"},{"issue":"1\u20133","key":"1177_CR30","first-page":"230","volume":"45","author":"FM van der Sande","year":"2018","unstructured":"van der Sande FM, Dekker MJ, Leunissen KML, Kooman JP. Novel insights into the pathogenesis and Prevention of Intradialytic Hypotension. Blood Purif. 2018;45(1\u20133):230\u20135.","journal-title":"Blood Purif"},{"issue":"7","key":"1177_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.15537\/smj.2021.42.7.20210082","volume":"42","author":"M Siddiqa","year":"2021","unstructured":"Siddiqa M, Kimber AC, Shabbir J. Multivariable prognostic model for dialysis patients with end stage renal disease: an observational cohort study of Pakistan by external validation. Saudi Med J. 2021;42(7):714\u201320.","journal-title":"Saudi Med J"},{"issue":"5","key":"1177_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2021.05.023","volume":"79","author":"AJ Hahr","year":"2022","unstructured":"Hahr AJ, Molitch ME. Management of diabetes Mellitus in patients with CKD: Core Curriculum 2022. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2022;79(5):728\u201336.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"2","key":"1177_CR33","first-page":"213","volume":"19","author":"DA Turner","year":"1978","unstructured":"Turner DA. An intuitive approach to receiver operating characteristic curve analysis. J Nucl Med. 1978;19(2):213\u201320.","journal-title":"J Nucl Med"},{"issue":"1","key":"1177_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21(1):6.","journal-title":"BMC Genomics"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-023-01177-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:21:15Z","timestamp":1700518875000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-023-01177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s13098-023-01177-9","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Beijing University of Chinese Medicine(No. 2022BZYLL0507). Participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Consent confirmatory letter is in additional files (Annex 2).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"199"}}